Patent · US Active

Microvesicles (MVS) derived from adult stem cells for use in the therapeutic treatment of a tumor disease

US9717760B2 · kind B2 · utility

0Cited by

3References

9Claims

0Family size

Assignee

Fresenius Medical Care Deutschland GmbH · DE

Inventors

Stefania Bruno · Torino, IT
Maria Beatriz Herrera Sanchez · Torino, IT
Valentina Fonsato · Pecetto Torinese, IT
Giovanni Camussi · Torino, IT
Ciro Tetta · Mirandola, IT

Key dates

Filing date	Feb 28, 2011
Grant date	Aug 1, 2017
Priority date	—
Expiry date	Jan 26, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is in the field of therapeutic treatment of tumors. The inventors have found that microvesicles derived from adult stem cells exert a remarkable anti-tumor effect when administered to a patient affected by a tumor disease. Preferred microvesicles are derived from a bone marrow-mesenchymal stem cell, a glomerular mesenchymal stem cell or a non-oval liver stem cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.